CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

M García-López; MP Ortega-García; M Diago; E Ortega-González; FJ López-Pérez; J Milara-Payá; A Bernalte-Sesé; P Blasco-Segura; J Cortijo-Gimeno

doi:10.1136/ejhpharm-2013-000436.65

Article info

Clinical Pharmacy

CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

Authors

M García-López 1Consorcio Hospital General Universitario, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
MP Ortega-García 1Consorcio Hospital General Universitario, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
M Diago 2Consorcio Hospital General Universitario, Hepatology, Valencia, Spain PubMed articles Google scholar articles
E Ortega-González 3Consorcio Hospital General Universitario, Infectious Disease Unit, Valencia, Spain PubMed articles Google scholar articles
FJ López-Pérez 1Consorcio Hospital General Universitario, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
J Milara-Payá 4Consorcio Hospital General Universitario, Research Foundation, Valencia, Spain PubMed articles Google scholar articles
A Bernalte-Sesé 1Consorcio Hospital General Universitario, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
P Blasco-Segura 1Consorcio Hospital General Universitario, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
J Cortijo-Gimeno 4Consorcio Hospital General Universitario, Research Foundation, Valencia, Spain PubMed articles Google scholar articles

Citation

García-López M, Ortega-García M, Diago M, et al

CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

European Journal of Hospital Pharmacy 2014;21:A27.

Publication history

First published February 24, 2014.

Online issue publication

September 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password